INKT MiNK Therapeutics, Inc.
Healthcare$10.44-3.96%ClosedMarket Cap: $52.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-4.11
P/S
0.00
EV/EBITDA
-3.59
DCF Value
$3,126.92
FCF Yield
-3207.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
76.0%
ROA
-120.2%
ROIC
-415.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-2.9M | $-2.7M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-3.3M | $-2.6M | $— | — |
| FY null | $0.00 | -Infinity% | $-12.5M | $-12.5M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-3.0M | $-2.9M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-3.7M | $-4.2M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-2.5M | $-2.8M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-2.2M | $-2.5M | $— | — |
| FY null | $0.00 | -Infinity% | $-10.7M | $-10.8M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-1.7M | $-1.8M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-2.9M | $-2.7M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-3.8M | $-3.8M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-5.5M | $-5.5M | $-1.58 | — |